← Back to Clinical Trials
Recruiting NCT07070843

NCT07070843 Effects of Two Different Eye Care Practices on Eye Complications in Mechanically Ventilated Intensive Care Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07070843
Status Recruiting
Phase
Sponsor Istanbul Saglik Bilimleri University
Condition Eye Care
Study Type INTERVENTIONAL
Enrollment 156 participants
Start Date 2025-07-01
Primary Completion 2026-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Days
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Control Group: Standard Eye Care GroupIntervention Group 1: Eye Care Using an Eye Care KitIntervention Group 2: Eye Care According to an Eye Care Protocol

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 156 participants in total. It began in 2025-07-01 with a primary completion date of 2026-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study was designed as a prospective, randomized controlled experimental study aiming to compare different approaches to eye care in intensive care patients receiving mechanical ventilation. In this study, patients receiving mechanical ventilation in the intensive care unit will be randomly assigned to four groups using a simple randomization method: 1. Control Group: Standard Eye Care 2. Intervention Group 1: Eye Care with Eye Care Kit 3. Intervention Group 2: Eye Care According to Eye Care Protocol 4. Intervention Group 3: Eye Care with Both Protocol and Eye Care Kit Research Hypotheses H1: Eye care provided using a care protocol is more effective in preventing the development of complications compared to standard eye care. H2: Eye care provided using an eye care kit is more effective in preventing the development of ocular complications compared to standard eye care. H3: The combined use of an eye care kit and a care protocol is more effective in preventing the development of ocular complications compared to using the care protocol alone. H4: The use of an eye care kit is more effective in preventing the development of ocular complications compared to the use of a care protocol.

Eligibility Criteria

Inclusion Criteria: * Age 18 years or older * Receiving mechanical ventilation * Glasgow Coma Scale (GCS) score \< 12 * At least 24 hours have passed since ICU admission * Baseline Schirmer test result indicating tear production \> 5 mm prior to study inclusion Exclusion Criteria: * Diagnosed with brain death * Presence of facial or ocular trauma * Patients with head trauma * Patients who have undergone brain surgery * Patients diagnosed with an eye infection or chemosis Withdrawal Criteria: * Patient's death during the study period * Extubation of the patient before completion of the care period

Contact & Investigator

Central Contact

Yildiz Deniz

✉ yildizdeniz142@gmail.com

📞 +905387251394

Principal Investigator

Yildiz Deniz

PRINCIPAL INVESTIGATOR

University of Health Sciences (Sağlık Bilimleri Üniversitesi)

Frequently Asked Questions

Who can join the NCT07070843 clinical trial?

This trial is open to participants of all sexes, aged 18 Days or older, studying Eye Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07070843 currently recruiting?

Yes, NCT07070843 is actively recruiting participants. Contact the research team at yildizdeniz142@gmail.com for enrollment information.

Where is the NCT07070843 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07070843 clinical trial?

NCT07070843 is sponsored by Istanbul Saglik Bilimleri University. The principal investigator is Yildiz Deniz at University of Health Sciences (Sağlık Bilimleri Üniversitesi). The trial plans to enroll 156 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology